Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

NCT00100334 is registered in ClinicalTrials.gov with PRAECIS Pharmaceuticals Inc. as lead sponsor.

NCT NCT00100334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
Lead sponsor
PRAECIS Pharmaceuticals Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2004
Completion date
August 31, 2005
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease